CMR Surgical said it is on track to begin commercialization of its Versius Plus surgical robotic platform in 2026 in the ...

Strategic realignments, innovation-driven investments, and other transformative events shaped the orthopedic market in 2025.

FDA is removing barriers to real-world evidence in device applications, allowing the use of de-identified patient data from ...

Edwards pushes CMS to expand Medicare TAVR coverage as agency opens public comment period through January 2026 for decision.

These were among our most popular Trivia Tuesday articles this past year. Amanda Pedersen is a veteran journalist and ...

David Fischel, Stereotaxis CEO, talks about the market opportunity for the company’s surgical robotic solutions.

This week in Pedersen’s POV, MD+DI Senior Editor Amanda Pedersen explores the potential over-reliance on a medical device ...

B. Braun said it has launched the Supply Assurance Program to boost supply chain resiliency and ensure uninterrupted patient ...

Comparative trials are among the hardest studies to execute in medtech, especially when the control arm is a long-established standard of care. Arun Menawat, CEO of Profound Medical, understands how ...

Philips acquires SpectraWave as medtech deals increase in December, with AI-powered coronary imaging technology boosting portfolio.

The medtech job market faces major shifts in 2026 due to federal layoffs, AI adoption, and M&A activity. Versatile skills ...

Building FDA submissions like a solid house requires early collaboration, proactive planning, and a clear regulatory story.